Preliminary studies indicate that the compound – a dual stimulator of incretin and glucose-dependent insulinotropic polypeptide receptors – presents a substantial improvement in weight reduction efforts . Beyond existing medications , the peptide appears to modify hunger and metabolic expenditure by means of separate routes. Although more analy